soul trial oral semaglutide cardiovascular outcomes results 2025 🧿 is the first oral GLP-1 RA proven to reduce MACE in high-risk T2DM patients, extending protection beyond injectable formulations. Trial: Oral Semaglutide & Cardiovascular in T2DM soul trial oral semaglutide cardiovascular

The high costs present significant reimbursement issues, especially when healthcare systems around the world are facing budget pressures due to increasing use of GLP-1 agonists worldwide, where global spending on this therapeutic area is projected to exceed USD 42 billion per year in 2025

Theres growing evidence that GLP1s may also have direct effects on liver fat metabolism, although this remains under investigation

FEBS letters, 238(2), 343346

However, tirzepatide increases the level of amino acids in BAT to a level similar to that after cold exposure

From entrepreneur Kylie Jenner and model Kendal Jenner spending a night in watching reality TV to Kendal and friend, model Hailey Biebers 'IV drip party' in Miami, this not-so-secret procedure is thought to give your body an added boost on days when you arent feeling 100%

Acknowledgements D.J.D